- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01514786
Decision Aid to Technologically Enhance Shared Decision Making (DATES)
September 10, 2017 updated by: Masahito Jimbo, MD, University of Michigan
Physicians face a challenge in promoting colorectal cancer screening (CRCS) in the face of multiple competing demands.
A decision aid (DA) that clarifies patient preferences and improves decision quality could aid shared decision making (SDM) and be effective at increasing CRCS rates.
However, exactly how such DA improves SDM is not clear.
This 4-year R01 study funded by the National Cancer Institute seeks to provide detailed understanding of how an interactive DA affects patient-physician communication and SDM, and ultimately CRCS adherence.
Study Overview
Detailed Description
This two-armed randomized controlled trial (300 patients/arm) will compare Colorectal Web (CW), the interactive DA, to a non-interactive control website in ten practices in Metro Detroit.
Patients will be adults aged 50 years and over, not current on CRCS.
In the clinic before the patient-physician encounter, participants will complete a Patient Baseline Survey.
They will be randomized to CW or the control website.
Data will be collected after the patient reviews the respective website (Post-Intervention Survey), during the patient-physician encounter (digital audio recording), and after it (Post-Encounter Survey).
Chart audit will be performed six months after the encounter to determine whether the patient underwent CRCS.
Study Type
Interventional
Enrollment (Actual)
570
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Allen Park, Michigan, United States, 48101
- Children's and Family Medical Clinic
-
Allen Park, Michigan, United States, 48101
- Downriver Internists
-
Ann Arbor, Michigan, United States, 48106
- University of Michigan Family Medicine at Domino's
-
Ann Arbor, Michigan, United States, 48108
- University of Michigan Briarwood Family Medicine
-
Canton, Michigan, United States, 48187
- Dua Family Practice
-
Dearborn, Michigan, United States, 48124
- George C. Hawrot, MD
-
Detroit, Michigan, United States, 48201
- Andrew Thomas, MD
-
Detroit, Michigan, United States, 48224
- Morang Chester Clinic
-
Detroit, Michigan, United States, 48227
- Rice Lanzilote & Egan
-
Detroit, Michigan, United States, 48235
- David Williams, MD
-
Livonia, Michigan, United States, 48152
- IPC - Livonia Internal Medicine
-
Southfield, Michigan, United States, 48075
- Lonnie Joe Jr. MD
-
Woodhaven, Michigan, United States, 48183
- Mark W. Sawka, MD
-
Ypsilanti, Michigan, United States, 48197
- University of Michigan Family Medicine at Corner Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 50-75 years of age
- not current with colorectal cancer screening
- scheduled for HME, Health Maintenance Exam, or chronic care visit with participating physician
- able to read English
- current contact information
Exclusion Criteria:
- history of colon cancer or adenomatous polyps
- history of dementia or psychosis
- contraindication to CRCS
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Same information is presented in the control website as is found in the intervention website, but no interactive component: preferences and risk assessment.
|
|
|
Active Comparator: Intervention with Colorectal Website
Intervention website includes an interactive component including preferences and risk assessment.
|
The intervention arm will allow participants on Colorectal Web to manipulate their preferences for CRCS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits
Time Frame: 6 months following intervention a chart audit will be conducted to determine if CRCS was completed.
|
Chart audits were conducted 6 months after the participant's study visit to determine if screening had occurred and if the type of screen was the same as the participant's preferred type of screening.
|
6 months following intervention a chart audit will be conducted to determine if CRCS was completed.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Masahito Jimbo, MD, PhD, MPH, University of Michigan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Jimbo M, Sen A, Plegue MA, Hawley S, Kelly-Blake K, Rapai M, Zhang M, Zhang Y, Xie X, Ruffin MT 4th. Interactivity in a Decision Aid: Findings From a Decision Aid to Technologically Enhance Shared Decision Making RCT. Am J Prev Med. 2019 Jul;57(1):77-86. doi: 10.1016/j.amepre.2019.03.004. Epub 2019 May 23.
- Jimbo M, Kelly-Blake K, Sen A, Hawley ST, Ruffin MT 4th. Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial. Trials. 2013 Nov 11;14:381. doi: 10.1186/1745-6215-14-381.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
January 17, 2012
First Submitted That Met QC Criteria
January 20, 2012
First Posted (Estimate)
January 23, 2012
Study Record Updates
Last Update Posted (Actual)
September 15, 2017
Last Update Submitted That Met QC Criteria
September 10, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00044733
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Data is still being analyzed and papers written
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Colorectal Web
-
Dong PengActive, not recruitingColorectal Cancer | Metabolic DiseaseChina
-
University Hospital, Basel, SwitzerlandRecruitingColorectal OperationsSwitzerland
-
University of SurreyMinimal Access Therapy Training Unit; Ethicon Endo-Surgery (Europe) GmbHCompleted
-
Universitaire Ziekenhuizen KU LeuvenRecruitingIBD - Inflammatory Bowel DiseaseBelgium
-
Jafar BakhshaieNational Center for Complementary and Integrative Health (NCCIH)RecruitingOrthopedic Disorder | Upper Extremity Pain | Nontraumatic Injury | Risky Substance UseUnited States
-
Oregon Research InstituteCompleted
-
Umeå UniversitySkane University Hospital; Sahlgrenska University HospitalRecruitingColorectal Cancer | Diverticular Disease of Left Side of Colon | Anastomotic Leakage | Colorectal AnastomosisSweden
-
First Hospital of China Medical UniversityRecruitingColorectal Carcinoma | Day SurgeryChina
-
Seattle Children's HospitalCompletedChronic Pain | Headache | Central SensitisationUnited States
-
University of California, San FranciscoWithdrawnLymphoma | Leukemia | Plasma Cell Dyscrasia